DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Radionuclide therapy

Radionuclide therapy

  • Landscape Analysis of Phase 2/3 Clinical Trials of Targeted

    Landscape Analysis of Phase 2/3 Clinical Trials of Targeted

  • RADIO PHARMACEUTICALS  Production Control  Safety Precautions  Applications  Storage

    RADIO PHARMACEUTICALS  Production Control  Safety Precautions  Applications  Storage

  • Targeted Radiotherapeutics from 'Bench-To-Bedside'

    Targeted Radiotherapeutics from 'Bench-To-Bedside'

  • Bispecific Antibody Pretargeting of Radionuclides for Immuno^ Single

    Bispecific Antibody Pretargeting of Radionuclides for Immuno^ Single

  • The Evolving Landscape of Therapeutic and Diagnostic Radiopharmaceuticals

    The Evolving Landscape of Therapeutic and Diagnostic Radiopharmaceuticals

  • Radiotoxicity After Iodine-131 Therapy for Thyroid Cancer Using the Micronucleus Assay

    Radiotoxicity After Iodine-131 Therapy for Thyroid Cancer Using the Micronucleus Assay

  • EANM Procedure Guidelines for 131I-Meta-Iodobenzylguanidine (131I-Mibg) Therapy

    EANM Procedure Guidelines for 131I-Meta-Iodobenzylguanidine (131I-Mibg) Therapy

  • Molecular Imaging and Radionuclide Therapy of Pheochromocytoma and Paraganglioma in the Era of Genomic Characterization of Disease Subgroups

    Molecular Imaging and Radionuclide Therapy of Pheochromocytoma and Paraganglioma in the Era of Genomic Characterization of Disease Subgroups

  • Getting Oral Or Systemic Radiation Therapy

    Getting Oral Or Systemic Radiation Therapy

  • Dosimetry and Dosimetric Tools in Radionuclide Therapy, Including Results from a European Survey

    Dosimetry and Dosimetric Tools in Radionuclide Therapy, Including Results from a European Survey

  • Nuclear Medicine Is a Medicinal Specialty Involving the Application of Radioactive Substances in the Diagnosis and Treatment of Disease

    Nuclear Medicine Is a Medicinal Specialty Involving the Application of Radioactive Substances in the Diagnosis and Treatment of Disease

  • Clinical Development Safety Considerations

    Clinical Development Safety Considerations

  • Basic Premises to Molecular Imaging and Radionuclide Therapy – Part 1

    Basic Premises to Molecular Imaging and Radionuclide Therapy – Part 1

  • Future Supply of Medical Radioisotopes for the UK Report 2014

    Future Supply of Medical Radioisotopes for the UK Report 2014

  • Medical Sources of Radiation

    Medical Sources of Radiation

  • Safety Reports Series No.63

    Safety Reports Series No.63

  • The Future of Nuclear Medicine As an Independent Specialty

    The Future of Nuclear Medicine As an Independent Specialty

  • Molecular Targeting with Radionuclides: State of the Science*

    Molecular Targeting with Radionuclides: State of the Science*

Top View
  • Molecular Imaging Using Nanobodies
  • Dutch Society of Nuclear Medicine
  • Practical Advice for Radiopharmacy and Nuclear Medicine Services Managing Delivery Changes Due to Brexit
  • Clinical Utility of 18F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: a Systematic Review and Meta-Analysis
  • Radiochemistry, Production Processes, Labeling Methods, and Immunopet Imaging Pharmaceuticals of Iodine-124
  • A Perspective on the Radiopharmaceutical Requirements for Imaging and Therapy of Glioblastoma
  • A Picture of Modern Tc-99M Radiopharmaceuticals: Production, Chemistry, and Applications in Molecular Imaging
  • Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications
  • Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases
  • Targeted Radionuclide Therapy for Patients with Metastatic
  • Continuous Repetitive Data Acquisition with 123I-FP-CIT SPECT: Effects of Rotation Speed And
  • Radionuclide Metabolic Therapy Clinical Aspects, Dosimetry and Imaging
  • Targeted Radionuclide Therapy
  • A Primer for Radioimmunotherapy and Radionuclide Therapy
  • Hybrid Imaging in Conventional Nuclear Medicine
  • The SNM Practice Guideline for Therapy of Thyroid Disease with 131I 3.0*
  • Overlooked Potential of Positrons in Cancer Therapy Takanori Hioki1,3,4*, Yaser H
  • Prostate Cancer Imaging and Therapy


© 2024 Docslib.org    Feedback